BIOS Stock Overview
Bioservo Technologies AB (publ) develops and sells wearable muscle strengthening systems worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Bioservo Technologies AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.016 |
| 52 Week High | kr2.39 |
| 52 Week Low | kr0.011 |
| Beta | 0.80 |
| 1 Month Change | -33.33% |
| 3 Month Change | -96.30% |
| 1 Year Change | -99.15% |
| 3 Year Change | -99.90% |
| 5 Year Change | -99.83% |
| Change since IPO | -99.92% |
Recent News & Updates
Shareholder Returns
| BIOS | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -14.9% | -0.7% | -1.7% |
| 1Y | -99.2% | -8.8% | 8.1% |
Return vs Industry: BIOS underperformed the Swedish Medical Equipment industry which returned -2.2% over the past year.
Return vs Market: BIOS underperformed the Swedish Market which returned 1.5% over the past year.
Price Volatility
| BIOS volatility | |
|---|---|
| BIOS Average Weekly Movement | 31.2% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in SE Market | 13.0% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: BIOS's share price has been volatile over the past 3 months.
Volatility Over Time: BIOS's weekly volatility has increased from 19% to 31% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 20 | Petter Backgren | www.bioservo.com |
Bioservo Technologies AB (publ) develops and sells wearable muscle strengthening systems worldwide. The company offers Ironhand, a robotic grip that strengthens gloves; and Carbonhand, a revolutionary assistive device for people with impaired hand function. Its products have applications in foundry, logistics, warehousing, and construction sectors, as well as used in pre-assembly and assembly tasks.
Bioservo Technologies AB (publ) Fundamentals Summary
| BIOS fundamental statistics | |
|---|---|
| Market cap | kr1.36m |
| Earnings (TTM) | -kr46.93m |
| Revenue (TTM) | kr11.86m |
0.1x
P/S Ratio0.0x
P/E RatioIs BIOS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOS income statement (TTM) | |
|---|---|
| Revenue | kr11.86m |
| Cost of Revenue | kr10.28m |
| Gross Profit | kr1.58m |
| Other Expenses | kr48.51m |
| Earnings | -kr46.93m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Feb 20, 2024
| Earnings per share (EPS) | -0.55 |
| Gross Margin | 13.30% |
| Net Profit Margin | -395.68% |
| Debt/Equity Ratio | 0% |
How did BIOS perform over the long term?
See historical performance and comparison